Monica Gandhi, MD, MPH

Phone: 415-502-6285
UCSF Box: 1352
Email: [email protected]
UCSF Profile

Project Sponsor
 		Location(s) Topics Start End
Intervention to reduce drug use and HIV incidence among high PrEP priority partnered YMSM Hunter College United States HIV/AIDS, Treatment Adherence
HIV Clinical Fellowship Janssen, L.P. United States HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
AIDS Clinical Trials Group Brigham and Women's Hospital United States HIV/AIDS
Expanded Multidisciplinary NeuroAIDS Research Training to Improve HIV Outcomes in Nigeria Northwestern University Nigeria HIV/AIDS, Neurology and Mental Health, Dementia and Cognitive Impairment
Developing a Mentoring Network of Diverse Mental Health Professionals Utilizing the CNICS Platform NIH National Institute of Mental Health United States Residencies, Fellowships, and Postdoctoral Training
Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP NIH National Institute of Allergy and Infectious Disease Kenya HIV/AIDS, Women's Health, Treatment Adherence
Assessing Antiretroviral Exposure in Diverse Populations NIH National Institute of Allergy and Infectious Disease United States HIV/AIDS, Pharmacology and Drug Treatment
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials NIH National Institute of Allergy and Infectious Disease Uganda HIV/AIDS
Hair measures to assess adherence and explain outcomes in an HIV clinical trial NIH National Institute of Allergy and Infectious Disease United States HIV/AIDS, Treatment Adherence
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials NIH National Institute of Allergy and Infectious Disease Malawi; Uganda; Tanzania; Zambia; Zimbabwe; South Africa; India HIV/AIDS, Women's Health, Newborn and Infant Health, Treatment Adherence
Hair Extensions;: Using Hair Levels to Interpret Adherence, Effectiveness and Pharmacokinetics with Real-World Oral PrEP, the Vaginal Ring, and Injectables NIH National Institute of Allergy and Infectious Disease United States HIV/AIDS
Development of a point of care urine tenofovir immunoassay to distinguish adherence versus resistance-based HIV treatment failure Massachusetts General Hospital Uganda; South Africa HIV/AIDS, Treatment Adherence
Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence University of North Carolina at Chapel Hill (UNC) United States HIV/AIDS, Treatment Adherence
Measuring TB Drugs in Hair as a Tool to Monitor Adherence, Exposure and Response Johns Hopkins University United States Treatment Adherence
Determination of Reyataz (Atazanavir Sulfate) Levels in Hair: A New Assay and Possible Predictor for Long-Term Virologic Outcome Bristol-Myers Squibb Company United States Implementation and Behavioral Science, Treatment Adherence
Positive Health Access to Services and Treatment (PHAST) City and County of San Francisco United States HIV/AIDS, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Family Services Network - Ryan White HIV/AIDS Program U.S. Health Resources and Services Administration United States HIV/AIDS, Patient and Peer Education
Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare U.S. Health Resources and Services Administration United States HIV/AIDS